Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction

Cell Transplantation

Volumn 21, Issue 9, 2012, Pages 1931-1944

  Glass, Carley ^a   Singla, Dinender K ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Fibrosis; Heart; MMP; Stem cells; TIMP 1

Indexed keywords

CASPASE 3; GELATINASE B; PROTEIN KINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; FIBROSIS; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFECTION; VENTRICULAR REMODELING;

MUS;

EID: 84866338727     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X627561     Document Type: Article

References (48)

1. Bigelow, R. L.; Williams, B. J.; Carroll, J. L.; Daves, L. 1. K.; Cardelli, J. A. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro. Breast Cancer Res. Treat. 117:3144; 2009.
2. Boersma, E.; Mercado, N.; Poldermans, D.; Gardien, M.; Vos, J.; Simoons, M. L. Acute myocardial infarction. Lancet 361:847-858; 2003.
3. Boheler, K. R.; Czyz, J.; Tweedie, D.; Yang, H. T.; Anisimov, S. V.; Wobus, A. M. Differentiation of pluripotent embryonic stem cells into cardiomyocytes. Circ. Res. 91:189-201; 2002.
4. Chiu, R. C.; Zibaitis, A.; Kao, R. L. Cellular cardiomyoplasty: Myocardial regeneration with satellite cell implantation. Ann. Thorac. Surg. 60:12-18; 1995.
5. Collins, J. M.; Russell, B. Stem cell therapy for cardiac repair. J Cardiovasc. Nurs. 24:93-97; 2009.
6. Creemers, E. E.; Cleutjens, J. P.; Smits, J. F.; Daemen, M. J. Matrix metalloproteinase inhibition after myocardial infarction: A new approach to prevent heart failure? Circ. Res. 89:201-210; 2001.
7. Creemers, E. E.; Davis, J. N.; Parkhurst, A. M.; Leenders, P.; Dowdy, K. B.; Hapke, E.; Hauet, A. M.; Escobar, P. G.; Cleutjens, J. P.; Smits, J. F.; Daemen, M. J.; Zile, M. R.; Spinale, F. G. Deficiency of TIMP-1 exacerbates LV remodeling after myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 284:H364-H371; 2003.
8. Dasse, E.; Bridoux, L.; Baranek, T.; Lambert, E.; Salesse, S.; Sowa, M. L.; Martiny, L.; Trentesaux, C.; Petitfrere, E. Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/ p38alpha pathway. Leukemia 21:595-603; 2007.
9. Fatma, S.; Selby, D. E.; Singla, R. D.; Singla, D. K. Factors Released from embryonic stem cells stimulate c-kit-FlK-1+ve progenitor cells and enhance neovascularization. Antioxid. Redox Signal. 13:1857-1865; 2010.
10. Foadoddini, M.; Esmailidehaj, M.; Mehrani, H.; Sadraei, S. H.; Golmanesh, L.; Wahhabaghai, H.; Valen, G.; Khoshbaten, A. Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection. Eur. J. Cardiothorac. Surg. 39:233-240; 2011.
11. Glass, C.; Singla, D. K. ES cells overexpressing micro RNA-1attenuate apoptosis in the injured myocardium. Mol. Cell. Biochem. 357(1-2):135-141; 2011.
12. Haviernik, P.; Lahoda, C.; Bradley, H. L.; Hawley, T. S.; Ramezani, A.; Hawley, R. G.; Stetler-Stevenson, M.; Stetler-Stevenson, W. G.; Bunting, K. D. Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation. Oncogene 23: 9212-9219; 2004.
13. Ikonomidis, J. S.; Hendrick, J. W.; Parkhurst, A. M.; Herron, A. R.; Escobar, P. G.; Dowdy, K. B.; Stroud, R. E.; Hapke, E.; Zile, M. R.; Spinale, F. G. Accelerated LV remodeling after myocardial infarction in TIMP-1-deficient mice: Effects of exogenous MMP inhibition. Am. J. Physiol. Heart Circ. Physiol. 288:H149-H158; 2005.
14. Ji, L.; Fu, F.; Zhang, L.; Liu, W.; Cai, X.; Zhang, L.; Zheng, Q.; Zhang, H.; Gao, F. Insulin attenuates myocardial ischemia/reperfusion injury via reducing oxidative/ nitrative stress. Am. J. Physiol. Endocrinol. Metab. 298: E871-E880; 2010.
15. Jing, D.; Parikh, A.; Canty Jr., J. M.; Tzanakakis, E. S. Stem cells for heart cell therapies. Tissue Eng. Part B Rev. 14:393-406; 2008.
16. Jugdutt, B. I. Ventricular remodeling after infarction and the extracellular collagen matrix: When is enough enough? Circulation 108:1395-1403; 2003.
17. Kim, H.; Kim, S. W.; Nam, D.; Kim, S.; Yoon, Y. S. Cell therapy with bone marrow cells for myocardial regeneration. Antioxid. Redox Signal. 11:1897-1911; 2009.
18. Kim, Y. S.; Seo, D. W.; Kong, S. K.; Lee, J. H.; Lee, E. S.; Stetler-Stevenson, M.; Stetler-Stevenson, W. G. TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation. Cancer Lett. 269:37-45; 2008.
19. Kumar, D.; Hacker, T. A.; Buck, J.; Whitesell, L. F.; Kaji, E. H.; Douglas, P. S.; Kamp, T. J. Distinct mouse coronary anatomy and myocardial infarction consequent to ligation. Coron. Artery Dis. 16:41-44; 2005.
20. Kumar, D.; Jugdutt, B. I. Apoptosis and oxidants in the heart. J. Lab. Clin. Med. 142:288-297; 2003.
21. Kumar, D.; Kamp, T. J.; LeWinter, M. M. Embryonic stem cells: Differentiation into cardiomyocytes and potential for heart repair and regeneration. Coron. Artery Dis. 16:111-116; 2005.
22. Lambert, E.; Boudot, C.; Kadri, Z.; Soula-Rothhut, M.; Sowa, M. L.; Mayeux, P.; Hornebeck, W.; Haye, B.; Petitfrere, E. Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival. Biochem. J. 372:767-774; 2003.
23. Lambert, E.; Bridoux, L.; Devy, J.; Dasse, E.; Sowa, M. L.; Duca, L.; Hornebeck, W.; Martiny, L.; Petitfrere-Charpentier, E. TIMP-1 binding to proMMP-9/CD44 complex localized at the cell surface promotes erythroid cell survival. Int. J. Biochem. Cell Biol. 41:1102-1115; 2009.
24. Lindsay, M. M.; Maxwell, P.; Dunn, F. G. TIMP-1: A marker of left ventricular diastolic dysfunction and fibrosis in hypertension. Hypertension 40:136-141; 2002.
25. Liu, X. W.; Taube, M. E.; Jung, K. K.; Dong, Z.; Lee, Y. J.; Roshy, S.; Sloane, B. F.; Fridman, R.; Kim, H. R. Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells from extrinsic cell death: A potential oncogenic activity of tissue inhibitor of metalloproteinase-1. Cancer Res. 65:898-906; 2005.
26. Melo, L. G.; Pachori, A. S.; Kong, D.; Gnecchi, M.; Wang, K.; Pratt, R. E.; Dzau, V. J. Molecular and cell-based therapies for protection, rescue, and repair of ischemic myocardium: Reasons for cautious optimism. Circulation 109:2386-2393; 2004.
27. Menasche, P. Skeletal myoblasts and cardiac repair. J. Mol. Cell. Cardiol. 45:545-553; 2008.
28. Min, J. Y.; Yang, Y.; Converso, K. L.; Liu, L.; Huang, Q.; Morgan, J. P.; Xiao, Y. F. Transplantation of embryonic stem cells improves cardiac function in postinfarcted rats. J. Appl. Physiol. 92:288-296; 2002.
29. Moore, C. S.; Milner, R.; Nishiyama, A.; Frausto, R. F.; Serwanski, D. R.; Pagarigan, R. R.; Whitton, J. L.; Miller, R. H.; Crocker, S. J. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J. Neurosci. 31:6247-6254; 2011.
30. Muller-Ehmsen, J.; Whittaker, P.; Kloner, R. A.; Dow, J. S.; Sakoda, T.; Long, T. I.; Laird, P. W.; Kedes, L. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. 34:107-116; 2002.
31. Nelson, T. J.; Martinez-Fernandez, A.; Yamada, S.; Perez-Terzic, C.; Ikeda, Y.; Terzic, A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 120:408-416; 2009.
32. Ritter, L. M.; Garfield, S. H.; Thorgeirsson, U. P. Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun. 257:494-499; 1999.
33. Singla, D. K. Embryonic stem cells in cardiac repair and regeneration. Antioxid. Redox Signal. 11:1857-1863; 2009.
34. Singla, D. K.; Hacker, T. A.; Ma, L.; Douglas, P. S.; Sullivan, R.; Lyons, G. E.; Kamp, T. J. Transplantation of embryonic stem cells into the infarcted mouse heart: Formation of multiple cell types. J. Mol. Cell. Cardiol. 40:195-200; 2006.
35. Singla, D. K.; Lyons, G. E.; Kamp, T. J. Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am. J. Physiol. Heart Circ. Physiol. 293:H1308-H1314; 2007.
36. Singla, D. K.; McDonald, D. E. Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am. J. Physiol. Heart Circ. Physiol. 293:H1590-H1595; 2007.
37. Singla, D. K.; Singla, R. D.; Lamm, S.; Glass, C. TGF{beta}2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in the infarcted myocardium. Am. J. Physiol. Heart Circ. Physiol. 300:H1442-H1450; 2011.
38. Singla, D. K.; Singla, R. D.; McDonald, D. E. Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am. J. Physiol. Heart Circ. Physiol. 295:H907-H913; 2008.
39. Singla, D. K.; Sun, B. Transforming growth factor-beta2 enhances differentiation of cardiac myocytes from embryonic stem cells. Biochem. Biophys. Res. Commun. 332: 135-141; 2005.
40. Spinale, F. G. Matrix metalloproteinases: Regulation and dysregulation in the failing heart. Circ. Res. 90:520-530; 2002.
41. Teichholz, L. E.; Kreulen, T.; Herman, M. V.; Gorlin, R. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence of absence of asynergy. Am. J. Cardiol. 37:7-11; 1976.
42. Tejima, E.; Guo, S.; Murata, Y.; Arai, K.; Lok, J.; van, L. K.; Rosell, A.; Wang, X.; Lo, E. H. Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J. Neurotrauma 26:1935-1941; 2009.
43. Tsagaraki, I.; Tsilibary, E. C.; Tzinia, A. K. TIMP-1 interaction with alphavbeta3 integrin confers resistance to human osteosarcoma cell line MG-63 against TNF-alpha-induced apoptosis. Cell Tissue Res. 342:87-96; 2010.
44. Xie, H.; Tang, L. L.; Luo, X. H.; Wu, X. Y.; Wu, X. P.; Zhou, H. D.; Yuan, L. Q.; Liao, E. Y. Suppressive effect of dexamethasone on TIMP-1 production involves murine osteoblastic MC3T3-E1 cell apoptosis. Amino Acids 38: 1145-1153; 2010.
45. Yang, D. C.; Ma, S. T.; Tan, Y.; Chen, Y. H.; Li, D.; Tang, B.; Chen, J. S.; Su, X. H.; Li, G.; Zhang, X.; Yang, Y. J. Imbalance of matrix metalloproteinases/tissue inhibitor of metalloproteinase-1 and loss of fibronectin expression in patients with congestive heart failure. Cardiology 116:133-141; 2010.
46. Yang, Y.; Min, J. Y.; Rana, J. S.; Ke, Q.; Cai, J.; Chen, Y.; Morgan, J. P.; Xiao, Y. F. VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESCdifferentiated cells. J. Appl. Physiol. 93:1140-1151; 2002.
47. Zhang, F.; Pasumarthi, K. B. Embryonic stem cell transplantation: Promise and progress in the treatment of heart disease. BioDrugs 22:361-374; 2008.
48. Zhang, M.; Methot, D.; Poppa, V.; Fujio, Y.; Walsh, K.; Murry, C. E. Cardiomyocyte grafting for cardiac repair: Graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33:907-921; 2001.